Charles Schwab’s Corbus Pharmaceuticals CRBP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $470K | Sell |
68,148
-20,377
| -23% | -$141K | ﹤0.01% | 3161 |
|
|
2025
Q1 | $470K | Sell |
88,525
-9,357
| -10% | -$49.7K | ﹤0.01% | 3101 |
|
|
2024
Q4 | $1.16M | Buy |
97,882
+4,239
| +5% | +$50K | ﹤0.01% | 2862 |
|
|
2024
Q3 | $1.93M | Buy |
93,643
+64,800
| +225% | +$1.34M | ﹤0.01% | 2717 |
|
|
2024
Q2 | $1.31M | Buy |
+28,843
| New | +$1.31M | ﹤0.01% | 2836 |
|
|
2023
Q1 | – | Sell |
-3,314
| Closed | -$11K | – | 3557 |
|
|
2022
Q4 | $11K | Hold |
3,314
| – | – | ﹤0.01% | 3525 |
|
|
2022
Q3 | $17K | Hold |
3,314
| – | – | ﹤0.01% | 3488 |
|
|
2022
Q2 | $26K | Buy |
+3,314
| New | +$26K | ﹤0.01% | 3498 |
|
|
2022
Q1 | – | Sell |
-1,499
| Closed | -$28K | – | 3590 |
|
|
2021
Q4 | $28K | Hold |
1,499
| – | – | ﹤0.01% | 3554 |
|
|
2021
Q3 | $46K | Sell |
1,499
-15,668
| -91% | -$481K | ﹤0.01% | 3461 |
|
|
2021
Q2 | $943K | Sell |
17,167
-79
| -0.5% | -$4.34K | ﹤0.01% | 2949 |
|
|
2021
Q1 | $1.02M | Buy |
17,246
+2,345
| +16% | +$139K | ﹤0.01% | 2851 |
|
|
2020
Q4 | $559K | Sell |
14,901
-1,123
| -7% | -$42.1K | ﹤0.01% | 2949 |
|
|
2020
Q3 | $866K | Buy |
16,024
+10,530
| +192% | +$569K | ﹤0.01% | 2709 |
|
|
2020
Q2 | $1.38M | Sell |
5,494
-119
| -2% | -$30K | ﹤0.01% | 2543 |
|
|
2020
Q1 | $883K | Buy |
5,613
+393
| +8% | +$61.8K | ﹤0.01% | 2526 |
|
|
2019
Q4 | $856K | Buy |
5,220
+639
| +14% | +$105K | ﹤0.01% | 2647 |
|
|
2019
Q3 | $670K | Hold |
4,581
| – | – | ﹤0.01% | 2690 |
|
|
2019
Q2 | $953K | Buy |
4,581
+444
| +11% | +$92.4K | ﹤0.01% | 2588 |
|
|
2019
Q1 | $863K | Buy |
4,137
+525
| +15% | +$110K | ﹤0.01% | 2596 |
|
|
2018
Q4 | $633K | Sell |
3,612
-40
| -1% | -$7.01K | ﹤0.01% | 2680 |
|
|
2018
Q3 | $828K | Hold |
3,652
| – | – | ﹤0.01% | 2675 |
|
|
2018
Q2 | $554K | Buy |
3,652
+423
| +13% | +$64.2K | ﹤0.01% | 2772 |
|
|
2018
Q1 | $591K | Hold |
3,229
| – | – | ﹤0.01% | 2687 |
|
|
2017
Q4 | $688K | Buy |
3,229
+752
| +30% | +$160K | ﹤0.01% | 2635 |
|
|
2017
Q3 | $532K | Hold |
2,477
| – | – | ﹤0.01% | 2701 |
|
|
2017
Q2 | $469K | Buy |
+2,477
| New | +$469K | ﹤0.01% | 2715 |
|